TELERARE HEALTH Trademark
Trademark Overview
On Friday, June 28, 2024, a trademark application was filed for TELERARE HEALTH with the United States Patent and Trademark Office. The USPTO has given the TELERARE HEALTH trademark a serial number of 98624759. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, February 5, 2025. This trademark is owned by TeleRare Health, L.L.C.. The TELERARE HEALTH trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Consultancy in the field of the medical diagnosis of rare and genetic diseases; Consultancy in the field of the medical treatment of rare and genetic diseases; Providing medical information, consultancy and advisory services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services; Health care services, namely, disease management programs; Providing medical advice in the field of rare and genetic diseases
Providing medical research information in the field of clinical trials and treatments for rare and genetic diseases
General Information
| Serial Number | 98624759 |
| Word Mark | TELERARE HEALTH |
| Filing Date | Friday, June 28, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, February 5, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 25, 2025 |
Trademark Statements
| Goods and Services | Consultancy in the field of the medical diagnosis of rare and genetic diseases; Consultancy in the field of the medical treatment of rare and genetic diseases; Providing medical information, consultancy and advisory services; Remote monitoring of medical data for medical diagnosis and treatment; Telemedicine services; Health care services, namely, disease management programs; Providing medical advice in the field of rare and genetic diseases |
| NOT AVAILABLE | "HEALTH" |
| Goods and Services | Providing medical research information in the field of clinical trials and treatments for rare and genetic diseases |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 31, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, March 18, 2024 |
| First Use In Commerce Date | Friday, May 3, 2024 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 28, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, March 18, 2024 |
| First Use In Commerce Date | Friday, May 3, 2024 |
Trademark Owner History
| Party Name | TeleRare Health, L.L.C. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Eagan, MN 55121-2210 |
Trademark Events
| Event Date | Event Description |
| Friday, June 28, 2024 | NEW APPLICATION ENTERED |
| Tuesday, January 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 24, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 24, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, January 17, 2025 | ASSIGNED TO EXAMINER |
| Friday, January 31, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 31, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 31, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 19, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 24, 2025 | NON-FINAL ACTION E-MAILED |
